WO2024261531 - COMPOSITIONS AND METHODS TO MODULATE TUMOR MICROENVIRONMENT ASSOCIATED LONG NONCODING RNAS
National phase entry:
Publication Number
WO/2024/261531
Publication Date
26.12.2024
International Application No.
PCT/IB2024/000333
International Filing Date
21.06.2024
Title **
[English]
COMPOSITIONS AND METHODS TO MODULATE TUMOR MICROENVIRONMENT ASSOCIATED LONG NONCODING RNAS
[French]
COMPOSITIONS ET MÉTHODES POUR MODULER DES ARN LONGS NON CODANTS ASSOCIÉS À UN MICROENVIRONNEMENT TUMORAL
Applicants **
HAYA THERAPEUTICS SA
Inventors
OUNZAIN, Samir
MOLLER TORDENMALM, Emely
BLESSING, Daniel, Roman
Priority Data
63/523,001
23.06.2023
US
63/587,332
02.10.2023
US
63/651,270
23.05.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4813 | |
| EPO | Filing, Examination, Granting | 30131 | |
| Japan | Filing, Examination, Granting | 3071 | |
| South Korea | Filing, Examination, Granting | 3905 | |
| USA | Filing, Examination, Granting | 14340 |
Total:
56,260
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Disclosed herein are modulators of a long non-coding RNA (IncRNA), wherein an expression of the IncRNA is associated with an activation of a cancer-associated fibroblast (CAP). Further provided herein are methods of inhibiting a growth of a solid tumor or facilitating access to a solid tumor in a subject in need thereof.[French]
La divulgation concerne des modulateurs d'un long ARN non codant (ARNInc), une expression de l'ARNInc étant associée à l'activation d'un fibroblaste associé au cancer (CAP). La divulgation concerne en outre des méthodes d'inhibition de la croissance d'une tumeur solide ou de facilitation de l'accès à une tumeur solide chez un sujet en ayant besoin.